Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 2701 to 2750 of 3791 results for treatment

  1. LIVERFASt for assessing and monitoring liver fibrosis, activity and steatosis (MIB317)

    NICE has developed a medtech innovation briefing (MIB) on LIVERFASt for assessing and monitoring liver fibrosis, activity and steatosis .

    Medtech innovation briefing
    Published
    21 February 2023

  2. Thiazide: In people with acute heart failure and persistent congestion, does the addition of a thiazide diuretic to standard therapy lead to greater diuresis compared with adding placebo to standard therapy?

    hospital for treatment of decompensated heart failure. One of the most common and difficult to manage problems arising during the...

    Research recommendation
    Published
    16 December 2021

  3. Routine outcome measurement:- In people with a common mental health disorder, what is the clinical utility of routine outcome measurement and is it cost effective compared with standard care?

    improved treatment outcomes, because of its impact on healthcare professionals' behaviour and the prompter availability of appropriate...

    Research recommendation
    Published
    9 June 2015

  4. Remote ECG interpretation consultancy services for cardiovascular disease (MIB152)

    NICE has developed a medtech innovation briefing (MIB) on remote ECG interpretation consultancy services for cardiovascular disease .

    Medtech innovation briefing
    Published
    27 July 2018

  5. Are there subgroups of people with Graves' disease who have a particularly good response to antithyroid drugs?

    that continued follow-up of people who have undergone radioactive iodine treatment was important and the 'as low as reasonably...

    Research recommendation
    Published
    10 February 2020

  6. What is the clinical and cost effectiveness of dosimetry-guided radioactive iodine strategies for hyperthyroidism?

    that continued follow-up of people who have undergone radioactive iodine treatment was important and the 'as low as reasonably...

    Research recommendation
    Published
    10 February 2020

  7. What is the long-term clinical and cost effectiveness, including safety, of radioactive iodine for hyperthyroidism?

    that continued follow-up of people who have undergone radioactive iodine treatment was important and the 'as low as reasonably...

    Research recommendation
    Published
    10 February 2020

  8. Insertion of hydrogel keratoprosthesis (HTG42)

    Evidence-based recommendations on insertion of hydrogel keratoprosthesis. This involves putting an artificial cornea into place in a pocket made in the front part of the eye.

    HealthTech guidance
    Published
    23 June 2004
    View recommendations

    Sections for HTG42

  9. Second-line maintenance therapy in children and young people (under 16):- Is maintenance therapy more effective with a paediatric low dose of ICS plus a leukotriene receptor antagonist (LTRA) or with a paediatric low dose of ICS plus a long-acting beta2 agonist (LABA) in the treatment of asthma in children and young people (under 16) who have uncontrolled asthma on a paediatric low dose of ICS alone?

    paediatric low dose of ICS plus a long-acting beta2 agonist (LABA) in the treatment of asthma in children and young people (under 16)...

    Research recommendation
    Published
    18 October 2018

  10. Adults' uptake of and engagement with interventions for social anxiety disorder:- What methods are effective in improving uptake of and engagement with interventions for adults with social anxiety disorder?

    of people with social anxiety disorder never receive treatment; of those who do receive treatment many wait 10 years or...

    Research recommendation
    Published
    9 June 2015

  11. Sedation in under 19s: using sedation for diagnostic and therapeutic procedures (CG112)

    This guideline covers the assessment, preparation, training and monitoring needed when using sedation in people aged under 19. It aims to help healthcare professionals decide when sedation is the most clinically and cost effective option for reducing pain and anxiety during operations for children and young people.

    Clinical guideline
    Published
    15 December 2010
    View recommendations

    Sections for CG112

  12. MolecuLight i:X for wound imaging (MIB212)

    NICE has developed a medtech innovation briefing (MIB) on MolecuLight i:X for wound imaging .

    Medtech innovation briefing
    Published
    18 June 2020

  13. Microwave ablation for the treatment of liver metastases (IPG406)

    Interventional procedures, IPG406 - Issued: August 2011 --> This guidance has been updated and replaced by NICE interventional procedure guidance 553.

    Withdrawn guidance

  14. Cryotherapy as a primary treatment for prostate cancer (IPG145)

    We have moved interventional procedures guidance 145 to become HealthTech guidance 91. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  15. Ranibizumab for the treatment of diabetic macular oedema (TA237)

    This guidance has been updated and replaced by NICE technology appraisal guidance 274.

    Withdrawn guidance

  16. Sorafenib for the treatment of advanced hepatocellular carcinoma (TA189)

    This guidance has been replaced by NICE technology appraisal guidance 474.

    Withdrawn guidance

  17. Certolizumab pegol for the treatment of rheumatoid arthritis (TA186)

    This guidance has been updated and replaced by NICE technology appraisal guidance 375.

    Withdrawn guidance

  18. Trabectedin for the treatment of relapsed ovarian cancer (TA222)

    This guidance has been updated and replaced by NICE technology appraisal guidance 389.

    Withdrawn guidance

  19. Alteplase for the treatment of acute ischaemic stroke (TA122)

    This guidance has been updated and replaced by NICE technology appraisal guidance 264 issued in September 2012.

    Withdrawn guidance

  20. Glitazones in the treatment of type 2 diabetes (TA63)

    This guidance has been updated and replaced by NICE guideline CG66 [partially updated by NICE guideline CG87]).

    Withdrawn guidance

  21. Desflurane for maintenance of anaesthesia (ES41)

    Summary of the evidence on desflurane for maintenance of anaesthesia

    Evidence summary
    Published
    26 March 2024

  22. For people with moderate and severe alcohol dependence who have significant comorbid problems, is an intensive residential rehabilitation programme clinically and cost effective when compared with intensive community-based care?

    those with severe problems and complex comorbidities, do not benefit from treatment and/or lose contact with services. One common...

    Research recommendation
    Published
    9 June 2015

  23. Risk tools to identify risk of developing COAG and risk of sight loss:- What is the predictive value of risk tools for identifying people in the community who are atincreased risk of developing chronic open angle glaucoma (COAG) and identifying people with COAG who are at increased risk of sight loss?

    conversion to COAG is important for guiding decisions about monitoring, treatment and referral. However, current evidence on the...

    Research recommendation
    Published
    18 October 2018

  24. Ectopic pregnancy and miscarriage (QS69)

    This quality standard covers the diagnosis and initial management of ectopic pregnancy and miscarriage in women in their first trimester (up to 13 completed weeks of pregnancy). It includes assessment and diagnosis for women with suspected early pregnancy loss. It describes high-quality care in priority areas for improvement.

    Quality standard
    Published
    10 September 2014
    View quality statements

    Sections for QS69

  25. What methods can improve the identification of women at high risk of postpartum psychosis and reduce this risk?

    increased risk of mortality in both the woman and her baby. Prophylactic treatment can be effective for women who are known to be at...

    Research recommendation
    Published
    9 June 2015

  26. Pulmonary hypertension:- What are the most clinical and cost-effective treatments for pulmonary hypertension in people with COPD?

    Pulmonary hypertension:- What are the most clinical and cost-effective treatments for pulmonary hypertension in people with COPD? Any...

    Research recommendation
    Published
    13 February 2019

  27. Vagus nerve stimulation for treatment-resistant depression (IPG330)

    This guidance has been updated and replaced by NICE HealthTech guidance 551.

    Withdrawn guidance

  28. ORA G3 to measure corneal hysteresis (MIB150)

    NICE has developed a medtech innovation briefing (MIB) on ORA G3 to measure corneal hysteresis .

    Medtech innovation briefing
    Published
    18 June 2018

  29. Dopamine: In people with acute heart failure, congestion and worsening renal function, does the addition of low‑dose dopamine to standard therapy lead to greater diuresis and renal protection compared with adding placebo to standard therapy?

    clinically and cost effective decongestion in people admitted to hospital for treatment of decompensated heart failure. The study should...

    Research recommendation
    Published
    16 December 2021

  30. Factors predicting outcomes for people with high-grade transformation of follicular lymphoma:- In people with high-grade transformation of follicular lymphoma, which biological and clinical factors predict good outcomes with immunochemotherapy alone?

    likely to do well with conventional treatment (such as R-CHOP) and which people may benefit from intensive treatment with,...

    Research recommendation
    Published
    25 August 2016

  31. CORTRAK 2 Enteral Access System for placing nasoenteral feeding tubes (MIB48)

    NICE has developed a medtech innovation briefing (MIB) on the CORTRAK 2 Enteral Access System for placing nasoenteral feeding tubes .

    Medtech innovation briefing
    Last updated
    9 December 2016

  32. Endovascular stent–grafts for the treatment of abdominal aortic aneurysms (TA167)

    This guidance has been updated and replaced by NICE guideline NG156.

    Withdrawn guidance

  33. Long-term safety of ovarian stimulation and ovulation induction for women:- Is there an association between ovulation induction or ovarian stimulation and adverse long-term (over 20 years) effects in women in the UK?

    significant long-term health issues, especially ovarian malignancy. Both treatments are common in the management of infertile women. The...

    Research recommendation
    Published
    9 June 2015

  34. Interim methods guide for developing service guidance 2014 (PMG8)

    This manual provides information additional to that in Developing NICE guidelines: the manual to guide developers on how to approach developing service guidance, and also to inform stakeholders about the steps that NICE will take in developing this guidance

  35. Interim process and methods guide for the clinical guideline updates using standing committees pilot programme 2013 (PMG17)

    This guide outlines the main elements of the interim process and methods for the NICE clinical guideline updates using standing committees pilot programme, including details of the Clinical Guidelines Updates committee, which were agreed by the NICE Board in September 2013

  36. Laparoscopic surgery for inguinal hernia repair (TA83)

    Evidence-based recommendations on laparoscopic surgery for treating inguinal hernia.

    Technology appraisal guidance
    Published
    22 September 2004
    View recommendations

    Sections for TA83

  37. Totally endoscopic robotically assisted coronary artery bypass grafting (HTG77)

    Evidence-based recommendations on totally endoscopic robotically assisted coronary artery bypass grafting (TECAB). This involves using small, remote-controlled robotic arms to carry out the grafting procedure.

    HealthTech guidance
    Published
    22 June 2005
    View recommendations

    Sections for HTG77

  38. Stent-graft placement in abdominal aortic aneurysm (HTG106)

    Evidence-based recommendations on stent-graft placement in abdominal aortic aneurysm. This involves patching the weakened section of the aorta with a graft mounted on a stent.

    HealthTech guidance
    Published
    22 March 2006
    View recommendations

    Sections for HTG106

  39. Endovascular closure of atrial septal defect (HTG58)

    Evidence-based recommendations on endovascular closure of atrial septal defect. This involves inserting a small blocking device into the heart, which is gently inflated to close the hole.

    HealthTech guidance
    Published
    27 October 2004
    View recommendations

    Sections for HTG58

  40. Individual versus group CBT for children and young people with social anxiety disorder:- What is the clinical and cost effectiveness of individual and group CBT for children and young people with social anxiety disorder?

    populations, however, indicate that individually-delivered treatments are associated with better treatment outcomes and are...

    Research recommendation
    Published
    9 June 2015

  41. Rimonabant for the treatment of overweight and obese adults (TA144)

    This appraisal has been withdrawn. This is because the marketing authorisation for rimonabant was withdrawn on 16 January 2009.

    Withdrawn guidance

  42. Etanercept and infliximab for the treatment of psoriatic arthritis (TA104)

    This guidance has been replaced by NICE technology appraisal guidance 199.

    Withdrawn guidance

  43. Effectiveness of the progestogen-only pill, injectable progestogens, or progestogen implants in alleviating HMB:- How effective are the progestogen-only pill, injectable progestogens or progestogen implants in alleviating HMB?

    is important:- Many women use LNG-IUS as the first-line pharmacological treatment for HMB, but it is not acceptable to all women....

    Research recommendation
    Published
    14 November 2018

  44. In well-defined generalised anxiety disorder (GAD), what is the clinical and cost effectiveness of two cognitive behavioural therapy (CBT) based low-intensity interventions (CCBT and guided bibliotherapy) compared with a waiting-list control?

    explanatory notes(if applicable) Why this is important:- Psychological treatments are a recommended therapeutic option for people with...

    Research recommendation
    Published
    9 June 2015

  45. In well-defined panic disorder, what is the clinical and cost effectiveness of two cognitive behavioural therapy (CBT) based low-intensity interventions (CCBT and guided bibliotherapy) compared with a waiting-list control?

    explanatory notes(if applicable) Why this is important:- Psychological treatments are a recommended therapeutic option for people with...

    Research recommendation
    Published
    9 June 2015

  46. The SpyGlass direct visualisation system for diagnostic and therapeutic procedures during endoscopy of the biliary system (MIB21)

    NICE has developed a Medtech Innovation Briefing (MIB) on the SpyGlass direct visualisation system for diagnostic and therapeutic procedures during endoscopy of

    Medtech innovation briefing
    Published
    12 February 2015

  47. What is the effectiveness, cost effectiveness and safety of the combination of casirivimab and imdevimab for treating COVID-19 in people with particular clinical characteristics (for example, people who are seropositive, of unknown serostatus, immunocompromised, or with specific comorbidities and within both the seropositive and seronegative groups, according to vaccination status or history of natural infection)?

    Outcome) P: hospitalised people with COVID-19I: treatment with a combination of casirivimab and imdevimabC:• treatment in...

    Research recommendation
    Published
    21 October 2021

  48. Percutaneous cementoplasty for palliative treatment of bony malignancies (IPG179)

    We have moved interventional procedures guidance 179 to become HealthTech guidance 117. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  49. Endovenous laser treatment of the long saphenous vein (IPG52)

    We have moved interventional procedures guidance 52 to become HealthTech guidance 26. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  50. Oseltamivir, amantadine (review) and zanamivir for the prophylaxis of influenza (TA158)

    Evidence-based recommendations on oseltamivir (Tamiflu), amantadine (Lysovir or Symmetrel) or zanamivir (Relenza) to prevent influenza (flu).

    Technology appraisal guidance
    Published
    24 September 2008
    View recommendations

    Sections for TA158